The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Celgene; Takeda
Consulting or Advisory Role - Celgene; Seagen
Speakers' Bureau - Amgen; Celgene; Takeda
Research Funding - Acetylon Pharmaceuticals; Amgen; BMS Brazil; Celgene; Janssen; Merck; Sanofi; Seagen
A phase Ib study of isatuximab in combination with pomalidomide (Pom) and dexamethasone (Dex) in relapsed/refractory multiple myeloma (RRMM).
 
Joseph Mikhael
Research Funding - Abbvie (Inst); Celgene (Inst); Sanofi (Inst)
 
Paul G. Richardson
Consulting or Advisory Role - Genmab
Research Funding - Celgene; Millennium
 
Saad Zafar Usmani
Consulting or Advisory Role - Amgen; Celgene; Janssen Oncology
Speakers' Bureau - Amgen; Celgene; Takeda
Research Funding - Array BioPharma; Celgene; Janssen Oncology; Millennium; Onyx; Pharmacyclics; Sanofi
 
Noopur Raje
Consulting or Advisory Role - Amgen; Celgene; Novartis; Takeda
Research Funding - AstraZeneca; Lilly
 
William Bensinger
No Relationships to Disclose
 
Dheepak Kanagavel
No Relationships to Disclose
 
Lei Gao
Employment - Sanofi
 
Samira Ziti-Ljajic
Employment - Sanofi
 
Kenneth Carl Anderson
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Gilead Sciences; Millennium
Patents, Royalties, Other Intellectual Property - Acetylon Pharmaceuticals; C4 Therapeutics; Oncopep